HAUPPAUGE, N.Y., July 11,
2024 /PRNewswire/ -- An in-vitro study by Dr.
A. Reza Kamarei, Dr. Howard F. Robins and Eric Finkelstein published in the International
Journal of Preventive Medicine and Care showed complete
inhibition of Epsilon Toxin-Producing Clostridium
perfringens with a juice-based probiotic Medical Food for
dietary management of Multiple Sclerosis (MF-MS).
Multiple sclerosis (MS) is the most common disabling
neurological disease in young adults, with symptom onset generally
occurring between the ages of 20 and 40 years. Worldwide, there are
2.8 million people with MS, and in the
United States, nearly 1 million. Currently, nine oral
medications are FDA-approved for MS, each of which has its own
undesirable side effects. The root cause of MS remains unknown, but
epsilon toxin-producing C. perfringens is implicated as the
cause or trigger. As an element of the gut microbiome, epsilon
toxin-producing C. perfringens may be managed through
dietary interventions, but there has not been any specific dietary
supplement or medical food available for this purpose…until
now!
"In our previous press release about Doctor's Biome Women's
Health dietary supplement, I promised that as we are continuing our
path, I will announce more novel products in a near future. I kept
my promise. Today, I am excited to announce that development of our
patent-pending pioneering Medical Food for people with
Multiple Sclerosis is complete. It is a good feeling to see the
mission we have chosen for the company "Be the Leader in
Juice-Based Clinically Validated Probiotics" is
achievable. Said Richard
Finkelstein, CEO of Doctor's Biome.
Dr. A. Reza Kamarei, Chief
Science and Technology Officer of Doctor's Biome explained: "We
are delighted that we have developed a patent-pending juice-based
probiotic medical food for the dietary management of MS that
inhibits the growth of both type B and type D epsilon
toxin-producing Clostridium perfringens - which, according to the
most recent published clinical findings, are thought to be the
cause or trigger of MS. This would have not been possible without
the valuable contributions and cooperations of Dr.
Howard Robins (Co-Founder and Chief
Medical Officer) and Mr. Eric
Finkelstein (Chief Operating Officer)".
Doctor's Biome Medical Food for dietary management of Multiple
Sclerosis (MF-MS) under the supervision of a physician is
manufactured with 60 billion colony-forming units (CFU) of
proprietary Doctor's Biome Signature Probiotic Blend (DBSPB) in 2
fl. oz of sterilized organic green fruit and vegetable juice.
Two strains of epsilon toxin-producing C. perfringens,
ATCC 3626 (type B) and ATCC 3631 (type D), were used as the target
pathogenic microorganisms. To our knowledge, this is the first
study in which a blend of proprietary pre-hydrated probiotics in a
proprietary sterilized liquid juice medium has completely inhibited
type B and type D epsilon toxin-producing C.
perfringens.
Doctor's Biome welcomes comments, questions, and co-sponsoring
clinical trials on Medical Food for dietary management of Multiple
Sclerosis (MF-MS).
About Doctor's Biome
Doctor's Biome (Newgen 27, LLC)
is a New York registered company
that develops, patents, manufactures and markets innovative,
science-based and clinically-tested probiotics in sterilized
organic vegetable/fruit juices.
Doctor's Biome
80 Davids Dr. Unit 2
Hauppauge, NY 11788
Website: www.DoctorsBiome.com
Contact Name: David
Finkelstein
Phone: 516-637-1651
Email: 380249@email4pr.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/doctors-biome-pioneering-medical-food-shows-promising-results-for-people-with-multiple-sclerosis-302193792.html
SOURCE Doctor's Biome